HRI Malta 2017—Cutting Edge Research in Homeopathy: HRI's Third International Research Conference in Malta

Abstract

The third international conference on “Cutting Edge Research in Homeopathy” organised by the Homeopathy Research Institute (HRI) was held on the inspiring and historic island of Malta from 9th to 11th of June, 2017. One hundred and two abstracts underwent peer review by the HRI Scientific Advisory Committee and external experts to produce the programme of 36 oral presentations and 37 posters, presented by researchers from 19 countries. The 2.5-day programme covered a diverse range of topics, including quantitative and qualitative clinical research, basic research, veterinary research, and provings. These intensive plenary and parallel sessions were interspersed with multiple opportunities for delegates to discuss and exchange ideas, in particular through interactive panel discussions and a pre-conference workshop. The continuing commitment of the homeopathy research community to generate high-quality studies in this rapidly evolving field was clear. In this conference report, we present highlights from this memorable event.

Keywords

homeopathy research - systematic review - antimicrobial resistance - conference - HRI - clinical trials - fundamental research

• References

• 1 Frass M, Friehs H, Thallinger C. , et al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients - a pragmatic randomized controlled trial. Complement Ther Med 2015; 23: 309-317
• 2 Macías-Cortés EdelC, Llanes-González L, Aguilar-Faisal L, Asbun-Bojalil J. Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP study): a randomized, double-dummy, double-blind, placebo-controlled trial. PLoS One 2015; 10: e0118440
• 3 World Health Organization (WHO). Global action plan on antimicrobial resistance. Available at: http://www.who.int/antimicrobial-resistance/global-action-plan/en/ . Accessed September 6, 2017
• 4 Mathie RT, Ramparsad N, Legg LA. , et al. Randomised, double-blind, placebo-controlled trials of non-individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev 2017; 6: 63
• 5 Homeopathy Research Institute (HRI). The Australian Report. Available at: https://www.hri-research.org/resources/homeopathy-the-debate/the-australian-report-on-homeopathy/. Accessed August 18, 2017
• 6 To KLA, Fok YYY, Chong KCM, Lee YCJ, Yiu LSS. Individualized homeopathic treatment in addition to conventional treatment in type II diabetic patients in Hong Kong - a retrospective cohort study. Homeopathy 2017; 106: 79-86
• 7 Walach H, Köster H, Hennig T, Haag G. The effects of homeopathic belladonna 30CH in healthy volunteers – a randomized, double-blind experiment. J Psychosom Res 2001; 50: 155-160
• 8 Walach H. Magic of signs: a non-local interpretation of homeopathy. Br Homeopath J 2000; 89: 127-140
• 9 Di Giorgio C, Boyer L, De Meo M, Laurant C, Elias R, Ollivier E. In vitro and in vivo antimutagenic effects of DIG, a herbal preparation of Berberis vulgaris, Taraxacum officinale and Arctium lappa, against mitomycin C. J Nat Med 2015; 69: 267-277
• 10 Cartwright SJ. Interaction of homeopathic potencies with the water soluble solvatochromic dye bis-dimethylaminofuchsone. Part 1: pH studies. Homeopathy 2017; 106: 37-46
• 11 Riley RD, Hayden JA, Steyerberg EW. , et al; PROGRESS Group. Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med 2013; 10: e1001380
• 12 Miglani A, Rutten L, Manchanda RK. Generalisability of prognostic factor research: further analysis of data from the IIPCOS2 study. Homeopathy 2017; 106: 155-159
• 13 National Health and Medical Research Council (NHMRC). Report on Homeopathy. Available at: https://www.nhmrc.gov.au/health-topics/complementary-medicines/homeopathy-review . Accessed September 6, 2017